NasdaqGM - Nasdaq Real Time Price USD
Kalaris Therapeutics, Inc. (KLRS)
3.3000
+0.1900
+(6.11%)
At close: June 6 at 4:00:01 PM EDT
3.3700
+0.07
+(2.12%)
After hours: June 6 at 7:39:22 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 128,852,492 | 84 |
| Sales | 2,907,707 | 189 |
| Net Shares Purchased (Sold) | 125,944,785 | 273 |
| Total Insider Shares Held | 3.22M | -- |
| % Net Shares Purchased (Sold) | -102.60% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| HAGEN BRETT R. Officer | Sale at price 8.97 per share. | Direct | 8,135 | Mar 26, 2025 |
| PATEL SAMIRBHAI CHANDRAKANTH M.D. Director | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 18, 2025 |
| FEINSOD MATTHEW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2025 |
| FERRARA NAPOLEONE Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 18, 2025 |
| AKKARAJU SRINIVAS Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) at price 0.00 per share. | Indirect | 0 | Mar 18, 2025 |
| SINHA VIKAS Chief Executive Officer | Sale at price 10.08 per share. | Direct | 3,053 | Feb 21, 2025 |
| MILLER EDWARD J.D. General Counsel | Sale at price 10.08 per share. | Direct | 1,068 | Feb 21, 2025 |
| HAGEN BRETT R. Officer | Sale at price 10.08 per share. | Direct | 967 | Feb 21, 2025 |
| SINHA VIKAS Chief Executive Officer | Sale at price 9.45 - 9.94 per share. | Direct | 1,226 | Jan 23, 2025 |
| MILLER EDWARD J.D. General Counsel | Sale at price 9.45 - 9.94 per share. | Direct | 494 | Jan 23, 2025 |
| HAGEN BRETT R. Officer | Sale at price 9.45 - 9.94 per share. | Direct | 342 | Jan 23, 2025 |
| SINHA VIKAS Chief Executive Officer | Sale at price 0.44 per share. | Direct | 431 | Jan 10, 2025 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.44 per share. | Direct | 180 | Jan 10, 2025 |
| HAGEN BRETT R. Officer | Sale at price 0.44 per share. | Direct | 146 | Jan 10, 2025 |
| MILLER EDWARD J.D. General Counsel | -- | Direct | -- | Dec 11, 2024 |
| SINHA VIKAS President | Sale at price 0.55 per share. | Direct | 1,748 | Nov 19, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.55 per share. | Direct | 237 | Nov 19, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.55 per share. | Direct | 304 | Nov 19, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.55 per share. | Direct | 4,775 | Nov 19, 2024 |
| SINHA VIKAS President | Sale at price 0.86 per share. | Direct | 4,442 | Nov 5, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.86 per share. | Direct | 1,965 | Nov 5, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.86 per share. | Direct | 1,431 | Nov 5, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.86 per share. | Direct | 9,176 | Nov 5, 2024 |
| SINHA VIKAS President | Sale at price 0.77 - 0.78 per share. | Direct | 2,649 | Oct 22, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.77 - 0.78 per share. | Direct | 1,083 | Oct 22, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.77 - 0.78 per share. | Direct | 746 | Oct 22, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.78 per share. | Direct | 7,597 | Oct 21, 2024 |
| SINHA VIKAS President | Sale at price 0.81 per share. | Direct | 766 | Oct 3, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.81 per share. | Direct | 307 | Oct 3, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.81 per share. | Direct | 245 | Oct 3, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.81 per share. | Direct | 1,216 | Oct 3, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.74 per share. | Direct | 3,996 | Aug 20, 2024 |
| SINHA VIKAS President | Sale at price 0.76 per share. | Direct | 2,399 | Aug 19, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.76 per share. | Direct | 321 | Aug 19, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.76 per share. | Direct | 413 | Aug 19, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.76 per share. | Direct | 2,348 | Aug 19, 2024 |
| SINHA VIKAS President | Sale at price 0.73 per share. | Direct | 3,858 | Aug 5, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.73 per share. | Direct | 1,707 | Aug 5, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.73 per share. | Direct | 1,243 | Aug 5, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.73 per share. | Direct | 7,970 | Aug 5, 2024 |
| SINHA VIKAS President | Sale at price 0.74 - 0.75 per share. | Direct | 2,530 | Jul 22, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.74 - 0.75 per share. | Direct | 1,035 | Jul 22, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.74 - 0.75 per share. | Direct | 715 | Jul 22, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.75 per share. | Direct | 7,299 | Jul 19, 2024 |
| SINHA VIKAS President | Sale at price 0.72 per share. | Direct | 676 | Jul 2, 2024 |
| MILLER EDWARD J.D. General Counsel | Sale at price 0.72 per share. | Direct | 273 | Jul 2, 2024 |
| HAGEN BRETT R. Officer | Sale at price 0.72 per share. | Direct | 219 | Jul 2, 2024 |
| BRAINARD DIANA Chief Executive Officer | Sale at price 0.72 per share. | Direct | 1,072 | Jul 2, 2024 |
| HALLAL DAVID L Director and Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Jun 6, 2024 |
| JOVAN-EMBIRICOS MORANA PH.D. Director and Beneficial Owner of more than 10% of a Class of Security | -- | Direct | -- | Jun 6, 2024 |
Related Tickers
4588.T Oncolys BioPharma Inc.
637.00
-4.07%
LIANY LianBio
0.3710
-1.33%
4592.T SanBio Company Limited
3,370.00
-0.30%
4565.T Nxera Pharma Co., Ltd.
944.00
+1.94%
4587.T PeptiDream Inc.
1,692.00
+0.53%
SQZB SQZ Biotechnologies Company
0.0280
-6.67%
MEDCL.PA MedinCell S.A.
16.14
-1.04%
6990.HK Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
350.800
+3.66%
PVLA Palvella Therapeutics, Inc.
25.40
+8.13%
NGNE Neurogene Inc.
21.83
-4.76%